213598-13-1

Basic information

• Product Name: 4-Methoxy-3-(Methylsulfonyl)benzoic Acid
• Synonyms: 4-Methoxy-3-(Methylsulfonyl)benzoic Acid
• CAS NO: 213598-13-1
• Molecular Formula: C₉H₁₀O₅S
• Molecular Weight: 230.2377
• Mol File: 213598-13-1.mol
• Article Data: 1

Chemical Properties

• Appearance: /
• Storage Temp.: Sealed in dry,Room Temperature
• CAS DataBase Reference: 4-Methoxy-3-(Methylsulfonyl)benzoic Acid(CAS DataBase Reference)
• NIST Chemistry Reference: 4-Methoxy-3-(Methylsulfonyl)benzoic Acid(213598-13-1)
• EPA Substance Registry System: 4-Methoxy-3-(Methylsulfonyl)benzoic Acid(213598-13-1)

Safety Data

• Hazardous Substances Data: 213598-13-1(Hazardous Substances Data)

Upstream product

• 83485-32-9 4-methoxy-3-methylsulfanyl-toluene 
• 87346-53-0 4-methoxy-3-methylsulphenylbenzoic acid 
• 50803-29-7 3-chlorosulfonyl-4-methoxybenzoic acid 
• 67745-31-7 3-mercapto-4-methoxy-benzoic acid 
• 83485-33-0 2-methoxy-5-methylbenzenethiol 
• 651729-63-4 3-chlorosulfonyl-4-methoxy-benzoyl chloride 
• 99-58-1 3-bromo-4-methoxybenzoic acid 
• 213598-20-0 3-Bromo-4-iso-propoxybenzoic Acid 

Relevant articles and documents

TETRAHYDROCYCLOPENTA[B]INDOL-3-YL CARBOXYLIC ACID DERIVATIVES USEFUL IN THE TREATMENT OF AUTOIMMUNE AND INFLAMMATORY DISORDERS

The present invention relates to certain (1,2,4-oxadiazol-3-yl)-1,2,3,4-tetrahydrocyclo-penta[b]indol-3-yl carboxylic acid derivatives of Formula (Ia) and pharmaceutically acceptable salts thereof, which exhibit useful pharmacological properties, for example, as agonists of the S1P1 receptor. Also provided by the present invention are pharmaceutical compositions containing compounds of the invention, and methods of using the compounds and compositions of the invention in the treatment of S1P1 associated disorders, for example, psoriasis, rheumatoid arthritis, Crohn's disease, transplant rejection, multiple sclerosis, systemic lupus erythematosus, ulcerative colitis, type I diabetes, acne, microbial infections or diseases and viral infections or diseases.